![Johnny Stilou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Johnny Stilou
Directeur Financier/CFO chez SCANDION ONCOLOGY A/S
Postes actifs de Johnny Stilou
Sociétés | Poste | Début | Fin |
---|---|---|---|
SCANDION ONCOLOGY A/S | Investor Relations Contact | - | - |
Directeur Financier/CFO | 01/08/2021 | - | |
Public Communications Contact | - | - | |
Directeur Général | 31/08/2022 | 02/01/2023 |
Historique de carrière de Johnny Stilou
Anciens postes connus de Johnny Stilou
Sociétés | Poste | Début | Fin |
---|---|---|---|
NUEVOLUTION AB (PUBL) | Directeur Financier/CFO | 01/01/2018 | 01/08/2021 |
Investor Relations Contact | - | 01/08/2021 | |
Fritz Schur Technical Group A/S
![]() Fritz Schur Technical Group A/S Wholesale DistributorsDistribution Services Part of FS 12 ApS, Fritz Schur Technical Group A/S is a Danish company that supplies industrial equipment. The company is based in Albertslund, Denmark. The CEO of the company is Mads-Ole Astrupgaard. | Directeur Financier/CFO | 01/01/2017 | 01/01/2018 |
VELOXIS PHARMACEUTICALS A/S | Comptroller/Controller/Auditor | 01/04/2008 | 01/08/2016 |
Directeur Technique/Scientifique/R&D | 02/06/2011 | 07/06/2013 | |
Directeur Financier/CFO | 02/06/2011 | 01/08/2016 | |
Conseiller Juridique Général | 02/06/2011 | 07/06/2013 | |
Silicon Labs Denmark | Directeur Financier/CFO | 01/01/2003 | 01/01/2007 |
Amgen Research (Munich) GmbH
![]() Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Directeur Financier/CFO | - | - |
Zensys, Inc.
![]() Zensys, Inc. Computer CommunicationsElectronic Technology Zensys, Inc. provides wireless communication services. It offers Z-Wave technology, a radio frequency-based mesh network and communications protocol, which enables everyday devices to be controlled & monitored wirelessly. The company also provides control & status reading application services for residential, energy management, access control, security and building automation. Zensys was founded in 2000 and is headquartered in Fremont, CA. | Directeur Financier/CFO | - | - |
Formation de Johnny Stilou
Copenhagen Business School | Graduate Degree |
Statistiques
Internationale
Danemark | 7 |
Etats-Unis | 2 |
Allemagne | 2 |
Opérationnelle
Director of Finance/CFO | 7 |
Investor Relations Contact | 2 |
Comptroller/Controller/Auditor | 1 |
Sectorielle
Health Technology | 4 |
Electronic Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Entreprise privées | 6 |
---|---|
Zensys, Inc.
![]() Zensys, Inc. Computer CommunicationsElectronic Technology Zensys, Inc. provides wireless communication services. It offers Z-Wave technology, a radio frequency-based mesh network and communications protocol, which enables everyday devices to be controlled & monitored wirelessly. The company also provides control & status reading application services for residential, energy management, access control, security and building automation. Zensys was founded in 2000 and is headquartered in Fremont, CA. | Electronic Technology |
Veloxis Pharmaceuticals A/S
![]() Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Nuevolution AB
![]() Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Fritz Schur Technical Group A/S
![]() Fritz Schur Technical Group A/S Wholesale DistributorsDistribution Services Part of FS 12 ApS, Fritz Schur Technical Group A/S is a Danish company that supplies industrial equipment. The company is based in Albertslund, Denmark. The CEO of the company is Mads-Ole Astrupgaard. | Distribution Services |
Silicon Labs Denmark | |
Amgen Research (Munich) GmbH
![]() Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Producer Manufacturing |
- Bourse
- Insiders
- Johnny Stilou
- Expérience